Subscribe
istock-866149824natee-meepian
Natee Meepian / iStockphoto.com
29 August 2018Americas

Purdue settles another OxyContin patent suit

Purdue Pharma has settled another patent dispute involving pain drug OxyContin (oxycodone), just weeks after a suit against generics company Amneal Pharmaceuticals came to an end.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Purdue and Amneal OxyContin clash ends
15 August 2018   A patent dispute over a generic version of Purdue Pharma’s drug OxyContin (oxycodone), which is used to treat moderate to severe pain, has come to an end.
Americas
Purdue continues OxyContin patent battle
10 October 2017   Purdue Pharma has sued Collegium Pharmaceutical, in the latest development in a continuing patent infringement dispute centring on Purdue’s painkiller drug OxyContin.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Americas
Purdue and Amneal OxyContin clash ends
15 August 2018   A patent dispute over a generic version of Purdue Pharma’s drug OxyContin (oxycodone), which is used to treat moderate to severe pain, has come to an end.
Americas
Purdue continues OxyContin patent battle
10 October 2017   Purdue Pharma has sued Collegium Pharmaceutical, in the latest development in a continuing patent infringement dispute centring on Purdue’s painkiller drug OxyContin.

More on this story

Americas
Purdue and Amneal OxyContin clash ends
15 August 2018   A patent dispute over a generic version of Purdue Pharma’s drug OxyContin (oxycodone), which is used to treat moderate to severe pain, has come to an end.
Americas
Purdue continues OxyContin patent battle
10 October 2017   Purdue Pharma has sued Collegium Pharmaceutical, in the latest development in a continuing patent infringement dispute centring on Purdue’s painkiller drug OxyContin.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB